Back to today’s briefing

Story perspectives

Trump Targets Drug Prices, Companies Seek Alternative Deals

2/12/2026

50 6 Full Breakdown

Summary

Story summary

U.S. President Donald Trump has targeted some drug pricing deals, while companies not targeted by him seek their own arrangements to avoid tariffs and price-setting schemes.
They are contacting the White House and Medicare officials for potential agreements.
Sixteen drugmakers have signed deals, including Pfizer and Eli Lilly.
Analysts say Medicaid's limited impact on drug spending may lessen the deals' effect.

1 of 1

Story summary

U.S. President Donald Trump has targeted some drug pricing deals, while companies not targeted by him seek their own arrangements to avoid tariffs and price-setting schemes.
They are contacting the White House and Medicare officials for potential agreements.
Sixteen drugmakers have signed deals, including Pfizer and Eli Lilly.
Analysts say Medicaid's limited impact on drug spending may lessen the deals' effect.